Skip to main content
. 2018 May 31;2018(5):CD011680. doi: 10.1002/14651858.CD011680.pub2

Comparison 3. IGIV versus placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Mortality within 30 days 1 100 Risk Ratio (M‐H, Random, 95% CI) 1.17 [0.42, 3.23]
2 Proportion of patients who experienced serious adverse events 1 100 Risk Ratio (M‐H, Random, 95% CI) 0.73 [0.32, 1.65]